Cite
Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
MLA
Matthias Frei, et al. “Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.” Clinical Pharmacokinetics, vol. 60, no. 11, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....060b376d3024cbe1cbc5c71300a70b49&authtype=sso&custid=ns315887.
APA
Matthias Frei, Corina Becker, Joachim Grevel, Lothar Roessig, Dirk Garmann, Rupert P. Austin, Michaela Meyer, Burkert Pieske, Dagmar Klein, & Hauke Ruehs. (2021). Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. Clinical Pharmacokinetics, 60(11).
Chicago
Matthias Frei, Corina Becker, Joachim Grevel, Lothar Roessig, Dirk Garmann, Rupert P. Austin, Michaela Meyer, Burkert Pieske, Dagmar Klein, and Hauke Ruehs. 2021. “Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.” Clinical Pharmacokinetics 60 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....060b376d3024cbe1cbc5c71300a70b49&authtype=sso&custid=ns315887.